These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8805647)

  • 21. HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.
    Burlingham WJ; Jankowska-Gan E; DeVito-Haynes L; Fechner JH; Hogan KT; Claas FH; Mulder A; Wang X; Ferrone S
    J Immunol; 1998 Dec; 161(12):6705-14. PubMed ID: 9862700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermodynamic and kinetic analysis of a peptide-class I MHC interaction highlights the noncovalent nature and conformational dynamics of the class I heterotrimer.
    Binz AK; Rodriguez RC; Biddison WE; Baker BM
    Biochemistry; 2003 May; 42(17):4954-61. PubMed ID: 12718537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus.
    Menssen R; Orth P; Ziegler A; Saenger W
    J Mol Biol; 1999 Jan; 285(2):645-53. PubMed ID: 9878435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding.
    Zarutskie JA; Sato AK; Rushe MM; Chan IC; Lomakin A; Benedek GB; Stern LJ
    Biochemistry; 1999 May; 38(18):5878-87. PubMed ID: 10231540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonapeptide analogues containing (R)-3-hydroxybutanoate and beta-homoalanine oligomers: synthesis and binding affinity to a class I major histocompatibility complex protein.
    Poenaru S; Lamas JR; Folkers G; López de Castro JA; Seebach D; Rognan D
    J Med Chem; 1999 Jul; 42(13):2318-31. PubMed ID: 10395472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.
    Wang W; Man S; Gulden PH; Hunt DF; Engelhard VH
    J Immunol; 1998 Feb; 160(3):1091-7. PubMed ID: 9570521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures.
    Shi Y; Smith KD; Lutz CT
    J Immunol; 1998 May; 160(9):4305-12. PubMed ID: 9574533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
    Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
    Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation.
    Smith KD; Epperson DF; Lutz CT
    Immunogenetics; 1996; 43(1-2):27-37. PubMed ID: 8537119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
    Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
    Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.
    Patarroyo ME; Alba MP; Vargas LE; Silva Y; Rosas J; Rodríguez R
    Biochemistry; 2005 May; 44(18):6745-54. PubMed ID: 15865420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules.
    Apostolopoulos V; Chelvanayagam G; Xing PX; McKenzie IF
    J Immunol; 1998 Jul; 161(2):767-75. PubMed ID: 9670953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling.
    Huczko EL; Bodnar WM; Benjamin D; Sakaguchi K; Zhu NZ; Shabanowitz J; Henderson RA; Appella E; Hunt DF; Engelhard VH
    J Immunol; 1993 Sep; 151(5):2572-87. PubMed ID: 8360479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes.
    Taketani S; Krangel MS; Spits H; de Vries J; Strominger JL
    J Immunol; 1984 Aug; 133(2):816-21. PubMed ID: 6429245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface.
    Malik P; Klimovitsky P; Deng LW; Boyson JE; Strominger JL
    J Immunol; 2002 Oct; 169(8):4379-87. PubMed ID: 12370371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR.
    Zhang QJ; Lindquist Y; Levitsky V; Masucci MG
    Int Immunol; 1996 Jun; 8(6):927-38. PubMed ID: 8671682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.
    Perosa F; Luccarelli G; Prete M; Favoino E; Ferrone S; Dammacco F
    J Immunol; 2003 Aug; 171(4):1918-26. PubMed ID: 12902494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80.
    Doménech N; Santos-Aguado J; López de Castro JA
    Hum Immunol; 1991 Feb; 30(2):140-6. PubMed ID: 1708752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.